Skip to main content
Log in

Montelukast als episodische Therapie bei frühkindlichem Asthma

Montelukast as intermittent therapy for infant asthma

  • Pädiatrische Pneumologie
  • Published:
Der Pneumologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Chauhan BF, Ducharme FM (2012) Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children. Cochrane Database Syst Rev 5:CD002314

    PubMed  PubMed Central  Google Scholar 

  2. Lemanske RF Jr., Mauger DT, Sorkness CA, Jackson DJ, Boehmer SJ, Martinez FD, Strunk RC, Szefler SJ, Zeiger RS, Bacharier LB, Covar RA, Guilbert TW, Larsen G, Morgan WJ, Moss MH, Spahn JD, Taussig LM, Childhood Asthma R, Education Network of the National Heart L, Blood I (2010) Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids. N Engl J Med 362:975–985

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Zeiger RS, Szefler SJ, Phillips BR, Schatz M, Martinez FD, Chinchilli VM, Lemanske RF Jr., Strunk RC, Larsen G, Spahn JD, Bacharier LB, Bloomberg GR, Guilbert TW, Heldt G, Morgan WJ, Moss MH, Sorkness CA, Taussig LM, Childhood Asthma R, Education Network of the National Heart L, Blood I (2006) Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma. J Allergy Clin Immunol 117:45–52

    Article  CAS  PubMed  Google Scholar 

  4. Klotsman M, York TP, Pillai SG, Vargas-Irwin C, Sharma SS, van den Oord EJ, Anderson WH (2007) Pharmacogenetics of the 5‑lipoxygenase biosynthetic pathway and variable clinical response to montelukast. Pharmacogenet Genomics 17:189–196

    Article  CAS  PubMed  Google Scholar 

  5. Brand PL, Baraldi E, Bisgaard H, Boner AL, Castro-Rodriguez JA, Custovic A, de Blic J, de Jongste JC, Eber E, Everard ML, Frey U, Gappa M, Garcia-Marcos L, Grigg J, Lenney W, Le Souef P, McKenzie S, Merkus PJ, Midulla F, Paton JY, Piacentini G, Pohunek P, Rossi GA, Seddon P, Silverman M, Sly PD, Stick S, Valiulis A, van Aalderen WM, Wildhaber JH, Wennergren G, Wilson N, Zivkovic Z, Bush A (2008) Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach. Eur Respir J 32:1096–1110

    Article  CAS  PubMed  Google Scholar 

  6. Nwokoro C, Pandya H, Turner S, Eldridge S, Griffiths CJ, Vulliamy T, Price D, Sanak M, Holloway JW, Brugha R, Koh L, Dickson I, Rutterford C, Grigg J (2014) Intermittent montelukast in children aged 10 months to 5 years with wheeze (WAIT trial): a multicentre, randomised, placebo-controlled trial. Lancet Respir Med 2:796–803

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Brand PL, Caudri D, Eber E, Gaillard EA, Garcia-Marcos L, Hedlin G, Henderson J, Kuehni CE, Merkus PJ, Pedersen S, Valiulis A, Wennergren G, Bush A (2014) Classification and pharmacological treatment of preschool wheezing: changes since 2008. Eur Respir J 43:1172–1177

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Gappa.

Ethics declarations

Interessenkonflikt

M. Gappa gibt an, dass kein Interessenkonflikt besteht.

Additional information

Redaktion

M. Gappa, Wesel

M. Rose, Frankfurt

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gappa, M. Montelukast als episodische Therapie bei frühkindlichem Asthma. Pneumologe 13, 200–202 (2016). https://doi.org/10.1007/s10405-016-0043-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10405-016-0043-4

Navigation